维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="Spathe K"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Neoadjvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in Intenational Federation of Gynecology and Obstetrics stage Ⅲ c ovarian carcinoma 显示文摘	Kuhn W Rutke S Spathe K	2001	Cancer2001，92，10：	1
2	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma 显示文摘	Kuhn W Rutke S Spathe K	2001	Cancer2001，92，10：	1
3	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics StageⅢ C ovarian carcinoma显示文摘	Kuhn W Rutke S Spathe K	2001	Cancer2001，92，：	1
4	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage Ⅲ C ovarian carcinoma 显示文摘	Kuhn W Rutke S Spathe K	2001	Cancer2001，92，10：	1
5	Neoadjvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in Intenational Federation of Gynecology and Obstetrics stage Ⅲc ovarian carcinoma显示文摘	Kuhn W Rutke S Spathe K	2007	Cancer2007，92，10：	1
6	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage ⅢC ovarian carcinoma显示文摘	Kuhn W Rutke S Spathe K	2001	Cancer2001，92，12：	1
7	Evaluation of reservation mechanisms in optical burst network 显示文摘	DOLZER K GAUGER C SPATH J	2001	AEU Int Journal of Electronic communication2001，55，21：	1
8	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage Ⅲ c ovarian carcinoma 显示文摘	Kuhn W Rutke S Spathe K	2001	Cancer2001，92，：	1
9	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage ⅢC ovarian carcinoma显示文摘	Rutke S Spathe K	2001	Cancer2001，92，10：	1
10	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma显示文摘	Kuhn W Rutke S Spathe K	2001	Cancer2001，92，10：	1
11	Update of hydrogen from biomass--determination of the delivered cost of hydrog en 显示文摘	Spath P L Mann M K Amos W A	2003	Milestone Completion Report2003，，：	1
12	Evaluation of reservation mechanisms in optical burst networks显示文摘	Dolzer K Gauger C Spath J	2001	AEU Int Journal of Electronic Communication2001，55，21：	1
13	Vaginal foreign body- cause for a rectovaginal fistula显示文摘	Rogenhofcr K Scharl A Spath G	2005	Zentralbl Gynakol2005，127，2：	1
14	Tissue factor procoagu-lant activity of plasma microparticles is increased in pa-tients with early-stage prostate cancer显示文摘	Haubold K Rink M Spath B	2009	Thromb Haem-ost2009，101，6：	1
15	Tissue factor pro-coagulant activity of plasma microparticles in patientswith cancer-associated disseminated intravascular coagu-lation显示文摘	Langer F Spath B Haubold K	2008	Ann Hematol2008，87，6：	1
16	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics stage lllc ovarian carcinoma显示文摘	Kuhu W Rutke S Spathe K	2001	Cancer2001，1592，10：	1
17	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in intemational Federation of Gyneoncology and Obstetrics Stage Ⅲ C ovarian carcinoma显示文摘	Kuhn W Rutke S Spathe K	2001	Cancer2001，92，：	1
18	Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patient with poor prognosis in International Federation of Gynecology and obstetrics stage Ⅲ c ovarian carcinoma显示文摘	Kuhu W Rutke S Spathe K	2001	Cancer2001，1592，10：	1
19	The origin and impact of embryonic aneuploidy显示文摘	Fragouli E Alfarawati S Spath K	2013	Hum Genet2013，132，9：	1
20	Tissue factor procoagulant activity of plasma microparticles is increased in patients with early- stage prostate cancer显示文摘	Haubold K Rink M Spath B	2009	ThrombHaemost2009，101，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示